Shanghai Gynecologic Oncology Group’s consensus on the academic and industry’s clinical trial types

Author:

Shi Tingyan1,Liu Jihong2,Zhu Jianqing3,Wang Xipeng4,Jiang Wei5,Lu Xin5,Feng Weiwei6,Zhou Shengtao7,Shen Yang8,Chen Gang9,Wu Zhenyu10,Zou Dongling11,Wu Peng12,Yang Huijuan13,Wu Sufang14,Zhu Tao3,Wang Huaying13,Zhang Yingli3,Qiu Lihua15,Guo Xiaoqing16,Xiang Libing1,Zhang Wei17,Ren Yulan13,Feng Yanling2,Liu Yanfei18,Chen Xiaojun19,Zang Rongyu1,

Affiliation:

1. Department of Gynecologic Oncology, Fudan University Zhongshan Hospital; Institute for Ovarian Cancer, Fudan University, Shanghai 200032, China

2. Department of Gynecologic Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong 528404, China

3. Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310005, China

4. Department of Obstetrics and Gynecology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China

5. Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200438, China

6. Department of Obstetrics and Gynecology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai 200025, China

7. Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE and State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610066, China

8. Department of Obstetrics and Gynecology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China

9. National Clinical Research Center for Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430073, China

10. School of Public Health, Key Laboratory of Public Health Safety and Collaborative Innovation Center of Social Risks Governance in Health, Fudan University, Shanghai 200433, China

11. Gynecologic Oncology Center, Chongqing University Cancer Hospital, Chongqing 400030, China

12. Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430073, China

13. Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China

14. Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

15. Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China

16. Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 200040, China

17. Biomedical Informatics & Statistics Center, School of Public Health, Fudan University, Shanghai 200433, China

18. Office of Clinical Research, Fudan University Shanghai Cancer Center, Shanghai 200032, China;

19. Department of Gynecology, the Tenth People’s Hospital of Tongji University, Shanghai 200072, China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3